Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-08-07
DOI
10.3389/fphar.2019.00883
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Species-specific differences in non-lysosomal glucosylceramidase GBA2 function underlie locomotor dysfunction arising from loss-of-function mutations
- (2019) Marina A. Woeste et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis
- (2018) Alexandre Henriques et al. Frontiers in Molecular Neuroscience
- Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
- (2018) Barry Boland et al. NATURE REVIEWS DRUG DISCOVERY
- Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons
- (2018) J. Magalhaes et al. Scientific Reports
- Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis
- (2017) P. Jésus et al. EUROPEAN JOURNAL OF NEUROLOGY
- Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate
- (2017) Anna Migdalska-Richards et al. SYNAPSE
- Glucocerebrosidase Mutations in Parkinson Disease
- (2017) Grace O’Regan et al. Journal of Parkinsons Disease
- Lipid Involvement in Neurodegenerative Diseases of the Motor System: Insights from Lysosomal Storage Diseases
- (2017) James C. Dodge Frontiers in Molecular Neuroscience
- The Enigmatic Role of GBA2 in Controlling Locomotor Function
- (2017) Marina A. Woeste et al. Frontiers in Molecular Neuroscience
- Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis
- (2017) Alexandre Henriques et al. Scientific Reports
- Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice
- (2016) Anna Migdalska-Richards et al. ANNALS OF NEUROLOGY
- Activation of -Glucocerebrosidase Reduces Pathological -Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons
- (2016) J. R. Mazzulli et al. JOURNAL OF NEUROSCIENCE
- Delineating pathological pathways in a chemically induced mouse model of Gaucher disease
- (2016) Ayelet Vardi et al. JOURNAL OF PATHOLOGY
- Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study
- (2016) Aya Narita et al. Annals of Clinical and Translational Neurology
- Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase
- (2015) Alexandre Henriques et al. HUMAN MOLECULAR GENETICS
- Glucocerebrosidase and Parkinson disease: Recent advances
- (2015) Anthony H.V. Schapira MOLECULAR AND CELLULAR NEUROSCIENCE
- Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells
- (2015) Giulia Ambrosi et al. NEUROBIOLOGY OF DISEASE
- Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis
- (2015) James C. Dodge et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD)
- (2015) Serena Lattante et al. TRENDS IN GENETICS
- Reducing GBA2 Activity Ameliorates Neuropathology in Niemann-Pick Type C Mice
- (2015) André R. A. Marques et al. PLoS One
- Magic shotgun for Parkinson’s disease?
- (2014) Roger L. Albin et al. BRAIN
- Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
- (2014) Alisdair McNeill et al. BRAIN
- Glutamate protects neuromuscular junctions from deleterious effects of β-amyloid peptide and conversely: An in vitro study in a nerve-muscle coculture
- (2014) Maud Combes et al. JOURNAL OF NEUROSCIENCE RESEARCH
- A plural role for lipids in motor neuron diseases: energy, signaling and structure
- (2014) Florent Schmitt et al. Frontiers in Cellular Neuroscience
- Exceptional Evolutionary Divergence of Human Muscle and Brain Metabolomes Parallels Human Cognitive and Physical Uniqueness
- (2014) Katarzyna Bozek et al. PLOS BIOLOGY
- β-Glucosidase 2 (GBA2) Activity and Imino Sugar Pharmacology
- (2013) Christina M. Ridley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Greater risk of parkinsonism associated with non-N370S GBA1 mutations
- (2012) M. J. Barrett et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Run for your life
- (2012) Timothy Noakes et al. NATURE
- Inhibitor screening of pharmacological chaperones for lysosomal β-glucocerebrosidase by capillary electrophoresis
- (2011) Meera Shanmuganathan et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis
- (2011) Sabrina Paganoni et al. MUSCLE & NERVE
- Ultrasensitive in situ visualization of active glucocerebrosidase molecules
- (2010) Martin D Witte et al. Nature Chemical Biology
- Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
- (2009) Gustavo H. B. Maegawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High metabolic level in patients with familial amyotrophic lateral sclerosis
- (2008) Benoit Funalot et al. Amyotrophic Lateral Sclerosis
- Dyslipidemia is a protective factor in amyotrophic lateral sclerosis
- (2008) L. Dupuis et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now